Alyeska Investment Group
SLS icon

Alyeska Investment Group’s SELLAS Life Sciences SLS Stock Holding History

Alyeska Investment Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-640,011
Closed -$693K – 652
2023
Q3 		$1.05M Sell
640,011
-609,989
-49% -$962K 0.01% 418
2023
Q2 		$1.96M Hold
1,250,000
– – 0.01% 411
2023
Q1 		$1.79M Buy
+1,250,000
New +$3.09M 0.02% 359
2022
Q3 		– Sell
-254,018
Closed -$566K – 479
2022
Q2 		$566K Buy
+254,018
New +$745K 0.01% 523

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Alyeska Investment Group's SLS Position: Q4 2023 in Review

Alyeska Investment Group sold out of SELLAS Life Sciences (SLS) in Q4 2023, closing a stake of 640,011 shares — an estimated $693K sold.

Alyeska Investment Group first reported a position in SLS in Q2 2022 and held it in 4 quarters. The position peaked at $1.96M in Q2 2023. 31 funds tracked by Wall St. Rank hold SLS as of Q4 2023.

  • Alyeska Investment Group reported no remaining SELLAS Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 640,011 SELLAS Life Sciences shares in Q4 2023, an estimated $693K.
  • Alyeska Investment Group first reported a position in SELLAS Life Sciences in Q2 2022 and held it in 4 quarters.
  • Alyeska Investment Group's SELLAS Life Sciences position peaked at $1.96M in Q2 2023.
  • 31 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.